Skip to content
drillr.ai
Sign up

ESLA

Estrella Immunopharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

Also listed · ESLAW →
$0.53
+0.57%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-41.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 26, 2026Liu Cheng · director, officer: CEOM-Exempt100,000$0.81
Aug 25, 2026Xu Jiandong · officer: Chief Financial OfficerM-Exempt100,000$0.81
Apr 29, 2026Xu Jiandong · officer: Chief Financial OfficerPurchase100$1.04
Apr 29, 2026Xu Jiandong · officer: Chief Financial OfficerPurchase1,000$1.16
Feb 14, 2025Liu Cheng · director, officer: Chief Executive OfficerA-Award509,204$0.81
Feb 14, 2025Liu Cheng · director, officer: Chief Executive OfficerA-Award490,796$0.81
Feb 14, 2025Xu Jiandong · officer: Chief Financial OfficerA-Award509,204$0.81
Feb 14, 2025Xu Jiandong · officer: Chief Financial OfficerA-Award490,796$0.81
Mar 17, 2022Li Jianwei · officer: Co-Chief Executive OfficerPurchase141,970$314.7K
Institutional positioning

13F filings over the trailing two quarters

New 10Increased 7Reduced 7Sold out 3
FilerActionSharesFiled
ARMISTICE CAPITAL, LLCNew Position4,099,000May 15, 2026
ARMISTICE CAPITAL, LLCReduced3,975,220Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased416,852Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position382,469May 15, 2026
WELLS FARGO & COMPANY/MNNew Position264,388Jul 8, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased157,485May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced141,321Aug 12, 2026
VANGUARD FIDUCIARY TRUST CONew Position64,921May 8, 2026
VANGUARD FIDUCIARY TRUST COUnchanged64,921Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLCReduced62,795May 14, 2026
BlackRock, Inc.Increased52,033Aug 7, 2026
STATE STREET CORPUnchanged43,252May 15, 2026
STATE STREET CORPUnchanged43,252Aug 7, 2026
BLACKROCK, INC.Increased39,890May 13, 2026
RENAISSANCE TECHNOLOGIES LLCReduced39,100Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026